Showing results (931-940 of 4,424) with videos related to
Sort By:
Pageof 443
Cancer Cell International|February 19, 2024
Signature construction and molecular subtype identification based on liver-specific genes for prediction of prognosis, immune activity, and anti-cancer drug sensitivity in hepatocellular carcinomaXiuzhi Zhang, Zhefeng Xiao, Xia Zhang, et al.Cancer Cell International|March 1, 2024
The circRNA hsa-circ-0013561 regulates head and neck squamous cell carcinoma development via the miR-7-5p/PDK3 axisKaisai Tian, Liying Zheng, Tailei Yuan, et al.Cancer Cell International|March 2, 2024
Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathwaysHadeel Kheraldine, Ishita Gupta, Farhan Sachal Cyprian, et al.Cancer Cell International|February 12, 2024
YY1: a key regulator inhibits gastric cancer ferroptosis and mediating apatinib-resistanceZi-Han Geng, Jun-Xian Du, Yue-Da Chen, et al.Cancer Cell International|February 9, 2024
PHF6 loss reduces leukemia stem cell activity in an acute myeloid leukemia mouse modelShengnan Yuan, Mingming Gao, Yizhou Wang, et al.Cancer Cell International|February 9, 2024
NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic routeObed Boadi Amissah, Wenfang Chen, Jean de Dieu Habimana, et al.Cancer Cell International|March 13, 2024
Immune modulation in malignant pleural effusion: from microenvironment to therapeutic implicationsShan Ge, Yuwei Zhao, Jun Liang, et al.Cancer Cell International|March 26, 2024
Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancerJie Li, Tian Yu, Juan Sun, et al.Cancer Cell International|April 3, 2024
CCDC25 suppresses clear cell renal cell carcinoma progression by LATS1/YAP-mediated regulation of the hippo pathwayHongpei Tan, Jiahao Liu, Yanan Li, et al.Cancer Cell International|March 30, 2024
β-hydroxybutyrate inhibits malignant phenotypes of prostate cancer cells through β-hydroxybutyrylation of indoleacetamide-N-methyltransferaseYifan Zhang, Yunlong LiPageof 443